Form 4: SelectQuote Director Acquires Shares, Receives RSU Grant

Sentiment:

Insider Transaction Report


SelectQuote Director Srdjan Vukovic reported the acquisition of 9,502 common shares and a new grant of 106,250 restricted stock units.

Summary

  • Director Srdjan Vukovic acquired 9,502 shares of SelectQuote, Inc. common stock on February 28, 2026, at a price of $0 per share.
  • This acquisition resulted from the vesting and conversion of 9,502 Restricted Stock Units (RSUs).
  • Vukovic also received a new grant of 106,250 Restricted Stock Units (RSUs) on November 11, 2025.
  • The 106,250 RSU award is scheduled to vest in full on the date of the Company's 2026 Annual Meeting of Stockholders, contingent on continued service on the Board of Directors.
  • Following these transactions, Vukovic directly owns 9,502 shares of common stock and 125,256 unvested Restricted Stock Units (comprising the 106,250 new grant and 19,006 remaining from a prior grant).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting continued director alignment with company performance through equity compensation, which is a standard and healthy practice.

Positives

  • Director Srdjan Vukovic received a new grant of 106,250 Restricted Stock Units, aligning his interests with long-term shareholder value.
  • The vesting of 9,502 Restricted Stock Units into common stock demonstrates the realization of equity compensation for continued service.

Risks

  • The vesting of the 106,250 Restricted Stock Units is contingent upon the recipient's continued service on the Board of Directors as of the 2026 Annual Meeting of Stockholders, posing a risk to the award if service ceases.
  • The vesting of the remaining 19,006 Restricted Stock Units is contingent upon the recipient's continued service on the Board of Directors as of the applicable vesting dates.

Future Outlook

The vesting schedules for the Restricted Stock Units indicate future equity compensation events for Director Srdjan Vukovic, contingent on his continued service on the Board of Directors through the 2026 Annual Meeting of Stockholders for the larger grant, and annually for the smaller remaining grant.

Industry Context

StockSavvy.ai notes that equity compensation, particularly through Restricted Stock Units, is a standard practice across industries to align the interests of directors and executives with long-term shareholder value. This filing reflects SelectQuote's ongoing use of such incentive plans to retain and motivate its leadership, a common strategy among publicly traded companies in the insurance and technology sectors.

Comparison to Industry Standards

  • The grant of Restricted Stock Units to a director is a common form of non-cash compensation, comparable to practices at peers like eHealth, Inc. (EHTH) or GoHealth, Inc. (GOCO), which also utilize equity awards to incentivize board members.
  • The vesting schedule, contingent on continued service, is a standard mechanism to ensure long-term commitment, aligning with corporate governance best practices seen in many S&P 500 companies.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Incentive Plan UtilizationThe Restricted Stock Units were granted pursuant to the Company's 2020 Omnibus Incentive Plan, indicating ongoing use of the plan for director compensation.11/11/2025Reinforces alignment of director interests with shareholder value through long-term equity incentives.

Stakeholder Impact

  • Shareholders: The grant and vesting of RSUs align the director's interests with long-term shareholder value, potentially fostering more strategic decision-making.
  • Employees: No direct impact on employees is noted, but the use of incentive plans can signal a commitment to performance-based compensation across the organization.

Next Steps

  • The 106,250 Restricted Stock Units are expected to vest in full on the date of SelectQuote's 2026 Annual Meeting of Stockholders, subject to continued service.
  • The remaining 19,006 Restricted Stock Units from a prior grant are expected to vest ratably in annual installments.

Key Dates

DateDescription
11/11/2025Date of grant for 106,250 Restricted Stock Units to Director Srdjan Vukovic.
02/28/2026Date of vesting and conversion of 9,502 Restricted Stock Units into common stock.
03/03/2026Signature date of the filing by Daniel A. Boulware, Attorney-in-Fact.
2026 Annual Meeting of StockholdersExpected vesting date for the 106,250 Restricted Stock Units, subject to continued service.
02/28/2035Expiration date for the 9,502 Restricted Stock Units (from a prior grant).
11/11/2035Expiration date for the 106,250 Restricted Stock Units (new grant).

Recommendation

hold

This Form 4 filing reports routine equity compensation events for a director, including a new RSU grant and the vesting of existing RSUs. While these actions demonstrate continued alignment of management interests with shareholders, they do not provide new fundamental information to warrant a change in investment recommendation. The transactions are expected and do not signal a significant shift in the company's outlook or valuation.

Keywords

SelectQuote, SLQT, Form 4, Insider Transaction, Restricted Stock Units, RSU, Equity Compensation, Director, Srdjan Vukovic, Stock Grant, Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.